The Top 10 News Stories of 2020
Though COVID-19 dominated the headlines, dentistry saw other significant developments in 2020 that will impact the way you practice long after the pandemic.
Todays Dental News
Industry News
Access to Telemedicine Varies for Head and Neck Cancer Patients
The use of telemedicine has been exceptionally effective in meeting the healthcare needs of patients throughout the COVID-19 pandemic, according to the Henry.
Industry News
Pinprick Blood Biomarker Test Identifies HPV-Related Cancers
A pinprick of blood may be enough to detect head, neck, and anal cancers linked to the HPV16 strain of the humanpapilloma virus.
Industry News
Deep Learning Detects Molecular and Genetic Alterations to Diagnose Cancer
A type of artificial intelligence known as deep learning successfully detected the presence of molecular and genetic alterations based only on tumor images.
Industry News
Combination Therapy Improves Head and Neck Cancer Treatment
Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy to treat advanced.
Industry News
Genetic Variant Drives Aggressive Head and Neck Cancer Growth
A genetic variant in a gene called MET is responsible for more aggressive growth in head and neck and in lung cancers, according.
Industry News
Blood Test Detects Presence and Location of Wide Range of Cancers
In a study involving thousands of participants, a new blood test detected more than 50 types of cancer including head and neck cancer.
Industry News
Oral Cancers Recruit and Reprogram Nerves to Fuel Growth When p53 Is Missing
The loss of the important p53 tumor-suppressing gene enables head and neck cancer to spin off signals to nearby nerves, changing their function.
Industry News
HPV-Positive Oropharyngeal Cancer Outcomes Differ by Race and Insurance Status
Survival outcomes for oropharyngeal squamous cell carcinoma of the head and neck (SCCHN) positive for the human papillomavirus (HPV) have made significant gains.
Industry News
Enrollment Continues in Study of Oral Mucositis Medication
Soligenix is actively enrolling patients in a Phase 3 multinational, double-blind, placebo-controlled clinical trial of SGX942, or dusquetide, for the treatment of oral mucositis.
